1978
DOI: 10.1016/s0008-6215(00)84141-5
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis of some cluster glycosides suitable for attachment to proteins or solid matrices

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1993
1993
2020
2020

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 119 publications
(2 citation statements)
references
References 11 publications
0
2
0
Order By: Relevance
“…[111] One of the very first glycodendrimer synthesis was reported by Yuan. [112] However, STARFISH was the first therapeutically significant development of an oligovalent dendron-like complex having analogs of Gb3 trisaccharide (Pk) covalently linked to the pentavalent glucose moiety (Figure 5b). It is well known that Gb3 carbohydrate is a ligand for the E. coli-based Shiga-like contaminants.…”
Section: Polyvalent Glycoengineered Molecules and Inhibitorsmentioning
confidence: 99%
“…[111] One of the very first glycodendrimer synthesis was reported by Yuan. [112] However, STARFISH was the first therapeutically significant development of an oligovalent dendron-like complex having analogs of Gb3 trisaccharide (Pk) covalently linked to the pentavalent glucose moiety (Figure 5b). It is well known that Gb3 carbohydrate is a ligand for the E. coli-based Shiga-like contaminants.…”
Section: Polyvalent Glycoengineered Molecules and Inhibitorsmentioning
confidence: 99%
“…Dendrimers are single molecular weight, globular structures which contain a central core, branching layers, and numerous functionalized end groups (Newkome and Shreiner, 2008, 2010). Though glycodendrimers have been synthesized for decades (Yuan, 1978), one of the first therapeutically relevant successes was the design of STARFISH; an oligovalent dendron-like compound bearing Gb 3 trisaccharide analogs (P k ) attached to a glucose pentavalent core (Figure 3A). The Gb 3 glycan is a known ligand for the multimeric Shiga-like toxins I and II, found in pathogenic E. coli .…”
Section: Engineered Glycans and Glycan Mimics As Therapeutic Agentsmentioning
confidence: 99%